Dawn Moore

Biography

Dawn Moore is a highly analytical, personable, goal-oriented, and collaborative professional with 15+ years of pharmaceutical research and development experience. Having worked in Development DMPK and quantitative bioanalysis in Pharma (including GSK, AstraZeneca, ViroPharma, and most recently Shire where she was responsible for Global Nonclinical/DMPK Operations), she has scientific expertise in bioanalytical chemistry, DMPK, toxicokinetics, and pharmacokinetics supporting nonclinical and clinical programs. Dawn was very excited to join the business development team at QPS in March of 2016. Dawn is located in Delaware, near QPS headquarters, and works with Rachel Whisnant to support all clients in the North East. As a team, they work with clients to utilize all of QPS’ nonclinical services and expertise in such areas as bioanalysis of small and large molecules, in vitro and in vivo ADME, biomarker analysis, nucleic acid drug and vector detection, and gene expression/genomics. Dawn looks forward to building long-term relationships with their clients and hopes to bring her scientific, technical operations and drug development experience to help their clients deliver their medicines to patients.

Research Interest

bioanalytical chemistry, DMPK, toxicokinetics, and pharmacokinetics